105 related articles for article (PubMed ID: 31236842)
1. A Method for Comprehensive Proteomic Analysis of Human Faecal Samples to Investigate Gut Dysbiosis in Patients with Cystic Fibrosis.
Debyser G; Aerts M; Van Hecke P; Mesuere B; Duytschaever G; Dawyndt P; De Boeck K; Vandamme P; Devreese B
Adv Exp Med Biol; 2019; 1073():137-160. PubMed ID: 31236842
[TBL] [Abstract][Full Text] [Related]
2. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis.
Debyser G; Mesuere B; Clement L; Van de Weygaert J; Van Hecke P; Duytschaever G; Aerts M; Dawyndt P; De Boeck K; Vandamme P; Devreese B
J Cyst Fibros; 2016 Mar; 15(2):242-50. PubMed ID: 26330184
[TBL] [Abstract][Full Text] [Related]
3. Technical report: In-gel sample preparation prior to proteomic analysis of bovine faeces increases protein identifications by removal of high molecular weight glycoproteins.
Huang Y; Burchmore R; Jonsson NN; Johnson PCD; Eckersall PD
J Proteomics; 2022 Jun; 261():104573. PubMed ID: 35351658
[TBL] [Abstract][Full Text] [Related]
4. Host-centric proteomics of stool: a novel strategy focused on intestinal responses to the gut microbiota.
Lichtman JS; Marcobal A; Sonnenburg JL; Elias JE
Mol Cell Proteomics; 2013 Nov; 12(11):3310-8. PubMed ID: 23982161
[TBL] [Abstract][Full Text] [Related]
5. Shotgun metaproteomics of the human distal gut microbiota.
Verberkmoes NC; Russell AL; Shah M; Godzik A; Rosenquist M; Halfvarson J; Lefsrud MG; Apajalahti J; Tysk C; Hettich RL; Jansson JK
ISME J; 2009 Feb; 3(2):179-89. PubMed ID: 18971961
[TBL] [Abstract][Full Text] [Related]
6. Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions.
Kolmeder CA; de Been M; Nikkilä J; Ritamo I; Mättö J; Valmu L; Salojärvi J; Palva A; Salonen A; de Vos WM
PLoS One; 2012; 7(1):e29913. PubMed ID: 22279554
[TBL] [Abstract][Full Text] [Related]
7. Genome-resolved metaproteomic characterization of preterm infant gut microbiota development reveals species-specific metabolic shifts and variabilities during early life.
Xiong W; Brown CT; Morowitz MJ; Banfield JF; Hettich RL
Microbiome; 2017 Jul; 5(1):72. PubMed ID: 28693612
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Metaproteomics and Activity-Based Probe Enrichment Reveals Significant Alterations in Protein Expression from a Mouse Model of Inflammatory Bowel Disease.
Mayers MD; Moon C; Stupp GS; Su AI; Wolan DW
J Proteome Res; 2017 Feb; 16(2):1014-1026. PubMed ID: 28052195
[TBL] [Abstract][Full Text] [Related]
9. Development of an enhanced metaproteomic approach for deepening the microbiome characterization of the human infant gut.
Xiong W; Giannone RJ; Morowitz MJ; Banfield JF; Hettich RL
J Proteome Res; 2015 Jan; 14(1):133-41. PubMed ID: 25350865
[TBL] [Abstract][Full Text] [Related]
10. Metaproteomic investigation to assess gut microbiota shaping in newborn mice: A combined taxonomic, functional and quantitative approach.
Levi Mortera S; Soggiu A; Vernocchi P; Del Chierico F; Piras C; Carsetti R; Marzano V; Britti D; Urbani A; Roncada P; Putignani L
J Proteomics; 2019 Jul; 203():103378. PubMed ID: 31102759
[TBL] [Abstract][Full Text] [Related]
11. Shotgun analysis of membrane proteomes by an improved SDS-assisted sample preparation method coupled with liquid chromatography-tandem mass spectrometry.
Lin Y; Jiang H; Yan Y; Peng B; Chen J; Lin H; Liu Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():6-14. PubMed ID: 23217299
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa Cell Membrane Protein Expression from Phenotypically Diverse Cystic Fibrosis Isolates Demonstrates Host-Specific Adaptations.
Kamath KS; Pascovici D; Penesyan A; Goel A; Venkatakrishnan V; Paulsen IT; Packer NH; Molloy MP
J Proteome Res; 2016 Jul; 15(7):2152-63. PubMed ID: 27246823
[TBL] [Abstract][Full Text] [Related]
13. Identification of Yersinia pestis and Escherichia coli strains by whole cell and outer membrane protein extracts with mass spectrometry-based proteomics.
Jabbour RE; Wade MM; Deshpande SV; Stanford MF; Wick CH; Zulich AW; Snyder AP
J Proteome Res; 2010 Jul; 9(7):3647-55. PubMed ID: 20486690
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.
Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P
J Cyst Fibros; 2013 May; 12(3):206-15. PubMed ID: 23151540
[TBL] [Abstract][Full Text] [Related]
15. Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis.
Li L; Krause L; Somerset S
Clin Nutr; 2017 Aug; 36(4):1097-1104. PubMed ID: 27595636
[TBL] [Abstract][Full Text] [Related]
16. Urinary pellet sample preparation for shotgun proteomic analysis of microbial infection and host-pathogen interactions.
Yu Y; Pieper R
Methods Mol Biol; 2015; 1295():65-74. PubMed ID: 25820714
[TBL] [Abstract][Full Text] [Related]
17. Isotope-labeling and affinity enrichment of phosphopeptides for proteomic analysis using liquid chromatography-tandem mass spectrometry.
Kota U; Chien KY; Goshe MB
Methods Mol Biol; 2009; 564():303-21. PubMed ID: 19544030
[TBL] [Abstract][Full Text] [Related]
18. Comparison of detergent-based sample preparation workflows for LTQ-Orbitrap analysis of the Escherichia coli proteome.
Tanca A; Biosa G; Pagnozzi D; Addis MF; Uzzau S
Proteomics; 2013 Sep; 13(17):2597-607. PubMed ID: 23784971
[TBL] [Abstract][Full Text] [Related]
19. The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.
Garg M; Ooi CY
Curr Gastroenterol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155088
[TBL] [Abstract][Full Text] [Related]
20. Assessing the impact of long term frozen storage of faecal samples on protein concentration and protease activity.
Morris LS; Marchesi JR
J Microbiol Methods; 2016 Apr; 123():31-8. PubMed ID: 26853125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
